230 related articles for article (PubMed ID: 34393171)
21. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.
Maisonobe L; Bertinchamp R; Damian L; Gérard L; Berisha M; Guillet S; Fieschi C; Malphettes M; Fadlallah J; Hié M; Dunogué B; De Wilde V; Vandergheynst F; Zafrani L; Grall M; Saada N; Garzaro M; Oksenhendler E; Galicier L; Boutboul D
Br J Haematol; 2022 Feb; 196(3):599-605. PubMed ID: 34585382
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
[TBL] [Abstract][Full Text] [Related]
23. TAFRO syndrome: A disease that known is half cured.
Chen T; Feng C; Zhang X; Zhou J
Hematol Oncol; 2023 Aug; 41(3):310-322. PubMed ID: 36148768
[TBL] [Abstract][Full Text] [Related]
24. TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease.
Shirakashi M; Nishida Y; Nakashima R; Fujimoto M; Hiwa R; Tsuji H; Kitagori K; Akizuki S; Morinobu A; Yoshifuji H
Sci Rep; 2024 Feb; 14(1):2889. PubMed ID: 38311632
[TBL] [Abstract][Full Text] [Related]
25. Tafro syndrome: Critical review for clinicians and pathologists.
Paydas S
Crit Rev Oncol Hematol; 2018 Aug; 128():88-95. PubMed ID: 29958635
[TBL] [Abstract][Full Text] [Related]
26. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
Minomo S; Fujiwara Y; Sakashita S; Takamura A; Nagata K
J Med Case Rep; 2021 Jan; 15(1):3. PubMed ID: 33402219
[TBL] [Abstract][Full Text] [Related]
27. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
[TBL] [Abstract][Full Text] [Related]
28. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
29. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
30. [TAFRO syndrome and cutaneous necrotizing vasculitis].
Maquet J; Bories E; Nogier MB; Beck C; Aizel G; Toledano A; Faguer S; Paricaud K; Pugnet G; Moulis G; Astudillo L; Sailler L
Rev Med Interne; 2021 Feb; 42(2):134-139. PubMed ID: 33218790
[TBL] [Abstract][Full Text] [Related]
31. TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly.
Miura K; Nishimaki-Watanabe H; Takahashi H; Nakagawa M; Otake S; Hamada T; Koike T; Iizuka K; Takeuchi Y; Kurihara K; Endo T; Ito S; Nukariya H; Namiki T; Hayashi Y; Nakamura H
Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927484
[TBL] [Abstract][Full Text] [Related]
32. Renal histological continuum of TAFRO syndrome: A case report and literature review.
Uemura T; Matsui M; Kokubu M; Samejima KI; Tsuruya K
Clin Nephrol; 2022 Feb; 97(2):121-128. PubMed ID: 34854374
[TBL] [Abstract][Full Text] [Related]
33. Treatment-resistant idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, renal dysfunction, and organomegaly managed with Janus kinase inhibitors: A case report.
Kakutani T; Nunokawa T; Chinen N; Tamai Y
Medicine (Baltimore); 2022 Dec; 101(48):e32200. PubMed ID: 36482523
[TBL] [Abstract][Full Text] [Related]
34. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
[TBL] [Abstract][Full Text] [Related]
35. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
[TBL] [Abstract][Full Text] [Related]
36. Complete Resolution of a Case of TAFRO Syndrome Accompanied by Mediastinal Panniculitis, Adrenal Lesion, and Liver Damage with Hyperbilirubinemia.
Ono S; Yoshimoto K; Nishimura N; Yoneima R; Kawashima H; Kobayashi T; Tai Y; Miyamoto M; Tsushima E; Yada N; Nishio K
Intern Med; 2021 Apr; 60(8):1303-1309. PubMed ID: 33191324
[TBL] [Abstract][Full Text] [Related]
37. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
[TBL] [Abstract][Full Text] [Related]
38. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
[TBL] [Abstract][Full Text] [Related]
39. Renal histology in a patient with TAFRO syndrome: a case report.
Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
[TBL] [Abstract][Full Text] [Related]
40. Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia.
Iizuka-Honma H; Takizawa H; Nitta H; Mitsumori T; Noguchi M
J Clin Exp Hematop; 2023; 63(1):32-36. PubMed ID: 36990774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]